Taurine attenuates d-[3H]aspartate release evoked by depolarization in ischemic corticostriatal slices

Brain Research

Volumn 1099, Issue 1, 2006, Pages 64-72

  Molchanova, Svetlana M ^a,c   Oja, Simo S ^b   Saransaari, Pirjo ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Corticostriatal slice; Depolarization; Glutamate; Ischemia; Taurine

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; BICUCULLINE; DEXTRO ASPARTIC ACID; GLUCOSE; GLUTAMIC ACID; GLYCINE RECEPTOR ANTAGONIST; GUANIDINOETHANESULFONIC ACID; STRYCHNINE; TAURINE; VERATRIDINE; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN SLICE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GLUCOSE BRAIN LEVEL; INCUBATION TIME; MALE; MEDICAL ASSESSMENT; MOUSE; NONHUMAN; OSMOSIS; PRIMARY AFFERENT DEPOLARIZATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TRANSPORT; SYNAPTIC MEMBRANE;

ANIMALS; ANOXIA; ASPARTIC ACID; BRAIN ISCHEMIA; CEREBRAL CORTEX; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; GLUCOSE; MALE; MICE; NEUROPROTECTIVE AGENTS; PSORALENS; STIMULATION, CHEMICAL; TAURINE; TRITIUM; VERATRIDINE;

MURINAE; STRYCHNOS TOXIFERA;

EID: 33746066402     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.04.105     Document Type: Article

References (59)

1. Arundine M., and Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 61 (2004) 657-668
2. Bak L.K., Schousboe A., and Waagepetersen H.S. Characterization of depolarization-coupled release of glutamate from cultured mouse cerebellar granule cells using dl-threo-beta-benzyloxyaspartate (dl-TBOA) to distinguish between the vesicular and cytoplasmic pools. Neurochem. Int. 43 (2003) 417-424
3. Belluzzi O., Puopolo M., Benedusi M., and Kratskin I. Selective neuroinhibitory effects of taurine in slices of rat main olfactory bulb. Neuroscience 124 (2004) 929-944
4. Bernath S. Calcium-independent release of amino acid neurotransmitters: fact or artifact?. Prog. Neurobiol. 38 (1992) 57-91
5. Chen W.Q., Jin H., Nguyen M., Carr J., Lee Y.J., Hsu C.C., Faiman M.D., Schloss J.V., and Wu J.Y. Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons. J. Neurosci. Res. 66 (2001) 612-619
6. Choi D.W., and Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13 (1990) 171-182
7. B receptors in rat hippocampal CA1 area. Brain Res. 864 (2000) 298-307
8. del Olmo N., Galarreta M., Bustamante J., and Martín del Río R. Taurine-induced synaptic potentiation: dependence on extra- and intracellular calcium stores. Adv. Exp. Med. Biol. 483 (2000) 283-292
9. Dohovics R., Janáky R., Varga V., Hermann A., Saransaari P., and Oja S.S. Regulation of glutamatergic neurotransmission in the striatum by presynaptic adenylyl cyclase-dependent processes. Neurochem. Int. 42 (2003) 1-7
10. El-Abhar H.S., and Abd El Gawad H.M. Modulation of cortical nitric oxide synthase, glutamate, and redox state by nifedipine and taurine in PTZ-kindled mice. Epilepsia 44 (2003) 276-281
11. El Idrissi A., and Trenkner E. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J. Neurosci. 19 (1999) 9459-9468
12. El Idrissi A., and Trenkner E. Taurine regulates mitochondrial calcium homeostasis. Adv. Exp. Med. Biol. 526 (2003) 527-536
13. El Idrissi A., and Trenkner E. Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem. Res. 29 (2004) 189-197
14. El Idrissi A., Messing J., Scalia J., and Trenkner E. Prevention of epileptic seizures by taurine. Adv. Exp. Med. Biol. 526 (2003) 515-525
15. Estevez A.Y., O'Regan M.H., Song D., and Phillis J.W. Hypoosmotically induced amino acid release from the rat cerebral cortex: role of phospholipases and protein kinases. Brain Res. 844 (1999) 1-9
16. Foos T.M., and Wu J.-Y. The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochem. Res. 27 (2002) 21-26
17. Frosini M., Sesti C., Dragoni S., Valoti M., Palmi M., Dixon H.B.F., Machetti F., and Sgaragli G. Interactions of taurine and structurally related analogues with the GABAergic system and taurine binding sites of rabbit brain. Br. J. Pharmacol. 138 (2003) 1163-1171
18. Frosini M., Sesti C., Saponara S., Ricci L., Valoti M., Palmi M., Machetti F., and Sgaragli G. A specific taurine recognition site in the rabbit brain is responsible for taurine effects on thermoregulation. Br. J. Pharmacol. 139 (2003) 487-494
19. García Dopico J., Perdomo Díaz J., Alonso T.J., González Hernández T., Castro Fuentes R., and Rodríguez Díaz M.R. Extracellular taurine in the substantia nigra: taurine-glutamate interaction. J. Neurosci. Res. 76 (2004) 528-538
20. Gunderson V., Shupliakov O., Brodin L., Ottersen O.P., and Storm-Mathisen J. Quantification of excitatory amino acid uptake at intact glutamatergic synapses by immunocytochemistry of exogeneous d-aspartate. J. Neurosci. 15 (1995) 4417-4428
21. Huxtable R.J. Taurine in the central nervous system and the mammalian actions of taurine. Prog. Neurobiol. 32 (1989) 471-533
22. Kamisaki Y., Maeda K., Ishmura M., Omura H., and Itoh T. Effects of taurine on depolarization-evoked release of amino acids from rat cortical synaptosomes. Brain Res. 627 (1993) 181-185
23. Kingston R., Kelly C.J., and Murray P. The therapeutic role of taurine in ischaemia-reperfusion injury. Curr. Pharm. Des. 10 (2004) 2401-2410
24. Kontro P., and Oja S.S. Co-operativity in sodium-independent taurine binding to brain membranes in the mouse. Neuroscience 23 (1987) 567-570
25. Kontro P., and Oja S.S. Glycinergic systems in the brain stem of developing and adult mice: effects of taurine. Int. J. Dev. Neurosci. 5 (1987) 461-470
26. B receptors in the brain. Prog. Clin. Biol. Res. 351 (1990) 83-94
27. Kreisman N.R., and Olson J.E. Taurine enhances volume regulation in hippocampal slices swollen osmotically. Neuroscience 120 (2003) 635-642
28. Lerma J., Herranz A.S., Herreras O., Abraira V., and Martín del Río R. In vivo determination of extracellular concentration of amino acids in the rat hippocampus. A method based on brain dialysis and computerized analysis. Brain Res. 384 (1986) 145-155
29. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79 (1999) 1431-1568
30. Louzada P.R., Lima A.C.P., Mendonca-Silva D.L., Noël F., De Mello F.G., and Ferreira S.T. Taurine prevents the neurotoxicity of β-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders. FASEB J. 18 (2004) 511-518
31. Malminen O., and Kontro P. Modulation of the GABA-benzodiazepine receptor complex by taurine in rat brain membranes. Neurochem. Res. 11 (1986) 85-94
32. 2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices. Neuropharmacology 45 (2003) 201-210
33. Messina S.A., and Dawson Jr. R. Attenuation of oxidative damage to DNA by taurine and taurine analog. Adv. Exp. Med. Biol. 483 (2000) 355-367
34. Miele M., Berners M., Boutelle M.G., Kusakabe H., and Fillenz M. The determination of the extracellular concentration of brain glutamate using quantitative microdialysis. Brain Res. 707 (1996) 131-133
35. Molchanova S., Oja S.S., and Saransaari P. Characteristics of basal taurine release in the rat striatum measured by microdialysis. Amino Acids 27 (2004) 261-268
36. Molchanova S., Oja S.S., and Saransaari P. Interstitial concentrations of amino acids in the rat striatum during global forebrain ischemia and potassium-evoked spreading depression. Neurochem. Res. 29 (2004) 1519-1527
37. 3H]d-aspartate outflow from various in vitro preparations of the rat hippocampus. Neurochem. Int. 31 (1997) 113-124
38. - neurotransmitter transporters. J. Neurochem. 71 (1998) 1785-1803
39. A subclass of GABA receptors. J. Neurochem. 74 (2000) 2087-2093
40. Oja S.S., and Saransaari P. Taurine as osmoregulator and neuromodulator in the brain. Metab. Brain Dis. 11 (1996) 153-164
41. Oja S.S., Korpi E.R., and Saransaari P. Modification of chloride flux across brain membranes by inhibitory amino acids in developing and adult mice. Neurochem. Res. 15 (1990) 797-804
42. Phillis J.W., and O'Regan M.H. Characterization of modes of release of amino acids in the ischemic/reperfused rat cerebral cortex. Neurochem. Int. 43 (2003) 461-467
43. Rivas-Arancibia S., Rodriguez A.I., Zigova T., Willing A.E., Brown W.D., Cahill D.W., and Sanberg P.R. Taurine increases rat survival and reduces striatal damage caused by 3-nitropropionic acid. Int. J. Neurosci. 108 (2001) 55-67
44. Roettger V., and Lipton P. Mechanism of glutamate release from rat hippocampal slices during in vitro ischemia. Neuroscience 75 (1996) 677-685
45. 3H]-d-aspartate from primary astrocyte cultures in response to raised external potassium. J. Neurosci. 16 (1996) 7803-7811
46. Saransaari P., and Oja S.S. Mechanisms of d-aspartate release under ischemic conditions in mouse hippocampal slices. Neurochem. Res. 24 (1999) 1009-1016
47. 3H]-d-aspartate release from hippocampal slices. Neurochem. Int. 38 (2001) 255-267
48. Schaffer S., Takahashi K., and Azuma J. Role of osmoregulation in the actions of taurine. Amino Acids 19 (2000) 527-546
49. Schuller-Levis G.B., and Park E. Taurine: new implications for an old amino acid. FEMS Microbiol. Lett. 226 (2003) 195-202
50. Seki Y., Feustel P.J., Keller Jr. R.W., Tranmer B.I., and Kimelberg H.K. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokainate and an anion channel blocker. Stroke 30 (1999) 433-440
51. Sergeeva O.A., Chepkova A.N., and Haas H.L. Guanidinoethyl sulphonate is a glycine receptor antagonist in striatum. Br. J. Pharmacol. 137 (2002) 855-860
52. Vornov J.J. Toxic NMDA-receptor activation occurs during recovery in a tissue culture model of ischemia. J. Neurochem. 65 (1995) 1681-1691
53. Wahl F., Obrenovitch T.P., Hardy A.M., Plotkine M., Boulu R., and Symon L. Extracellular glutamate during focal cerebral ischemia in rats: time course and calcium dependency. J. Neurochem. 63 (1994) 1003-1011
54. Wang J.X., Li Y., Zhang L.K., Zhao J., Pang Y.Z., Tang C.S., and Zhang J. Taurine inhibits ischemia/reperfusion-induced compartment syndrome in rabbits. Acta Pharmacol. Sin. 26 (2005) 821-827
55. Wu J.-Y., Tang X.W., and Tsai W.H. Taurine receptor: kinetic analysis and pharmacological studies. Adv. Exp. Med. Biol. 315 (1992) 263-268
56. Wu H., Jin Y., Wei J., Jin H., Sha D., and Wu J.-Y. Mode of action of taurine as a neuroprotector. Brain Res. 1038 (2005) 123-131
57. Ye G., Tse A., and Yung W. Taurine inhibits rat substantia nigra pars reticulata neurons by activation of GABA- and glycine-linked chloride conductance. Brain Res. 749 (1997) 175-179
58. Zhao P., Huang Y.-L., and Cheng J.-S. Taurine antagonizes calcium overload induced by glutamate or chemical hypoxia in cultured rat hippocampal neurons. Neurosci. Lett. 268 (1999) 25-28
59. Zheng L.X. Effect of 4-aminopyridine on taurine-regulated release of amino acid from rat cortical synaptosomes. Yao. Xue. Xue. Bao. 36 (2001) 307-309